Literature DB >> 11481576

Beyond the cholesterol profile: monitoring therapeutic effectiveness of statin therapy.

R G Schwartz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11481576     DOI: 10.1067/mnc.2001.116847

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  49 in total

1.  Improvement of impaired myocardial vasodilatation due to diffuse coronary atherosclerosis in hypercholesterolemics after lipid-lowering therapy.

Authors:  I Yokoyama; S Momomura; T Ohtake; K Yonekura; W Yang; N Kobayakawa; T Aoyagi; S Sugiura; N Yamada; K Ohtomo; Y Sasaki; M Omata; Y Yazaki
Journal:  Circulation       Date:  1999-07-13       Impact factor: 29.690

2.  The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group.

Authors:  L J Shaw; R Hachamovitch; D S Berman; T H Marwick; M S Lauer; G V Heller; A E Iskandrian; K L Kesler; M I Travin; H C Lewin; R C Hendel; S Borges-Neto; D D Miller
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

Review 3.  Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age.

Authors:  K A Brown
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

4.  Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor.

Authors:  J L Goldstein; S E Dana; G Y Brunschede; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

5.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

6.  Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis. A comparative study of genetic and environmental factors in 274 heterozygous cases.

Authors:  V Beaumont; B Jacotot; J L Beaumont
Journal:  Atherosclerosis       Date:  1976-09       Impact factor: 5.162

7.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

8.  Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin.

Authors:  M Guethlin; A M Kasel; K Coppenrath; S Ziegler; W Delius; M Schwaiger
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

9.  Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.

Authors:  O Hernández-Perera; D Pérez-Sala; J Navarro-Antolín; R Sánchez-Pascuala; G Hernández; C Díaz; S Lamas
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

View more
  2 in total

1.  Early insights of cardiac risk and treatment response with quantitative PET monitoring of coronary-specific endothelial dysfunction and myocardial perfusion reserve.

Authors:  Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2010-12       Impact factor: 5.952

2.  Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424.

Authors:  Leslee J Shaw; Gary V Heller; Paul Casperson; Romalisa Miranda-Peats; Piotr Slomka; John Friedman; Sean W Hayes; Ronald Schwartz; William S Weintraub; David J Maron; Marcin Dada; Spencer King; Koon Teo; Pamela Hartigan; William E Boden; Robert A O'Rourke; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2006-09       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.